Found 186 matching trials
Laboratory-Treated T Cells After Second-Line Chemotherapy in Treating Patients With HER2/Neu-Negative Metastatic Breast Cancer PHASE2 RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Show More Location
Barbara Ann Karmanos Cancer Institute
Learn More & Join Trial
COVID Protection After Transplant-Immunosuppression Reduction PHASE2 This study will enroll individuals who have:
* Completed primary series of...
Show More Location
University of California, San Diego
Learn More & Join Trial
A Study Comparing LBEC0101 to Enbrel® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy PHASE3 This is a randomized, double-blind, parallel group, multicenter clinical st...
Show More Location
Mochida Investigational site
Learn More & Join Trial
Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer(CONTROL-01) PHASE2 To evaluate the safety and preliminary efficacy of preoperative chemotherap...
Show More Location
The affiliated hospital of Qingdao university
Learn More & Join Trial
Iguratimod as Treatment for Refractory Lupus Nephritis NA This study is to evaluate the efficacy and safety of a novel chemical synth...
Show More Learn More & Join Trial
Humoral and Cellular Immunity Against SARS-COV-2 Vaccine in HIV-infected Patients Immunosuppressed N/A Prospective, non-equality, cohort study, where investigators propose to ana...
Show More Location
Virgen del Rocio University Hospital
Learn More & Join Trial
Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients N/A This study is to evaluate available local data in Iraqi patients with rheum...
Show More Learn More & Join Trial
Evaluate Efficacy, Immunological Response of Intratumoral/Intralesional Oncolytic Virus (OBP-301) in Metastatic Melanoma PHASE2 Open-label, single-arm, multi-center, Phase IIa study to evaluate the effic...
Show More Learn More & Join Trial
Lactobacillus Johnsonii in Children and Adolescents With T1D PHASE2 While genetics demonstrated a major risk factor for the development of type...
Show More Location
UF Clinical Research Center
Learn More & Join Trial
CAR T-cell Therapy in Combination With Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma With High-Risk Prognostic Factors PHASE2 The aim of this study is to evaluate the efficacy and safety of CAR T-cell ...
Show More Location
Shanghai Ruijin Hospital
Learn More & Join Trial